Related Experiment Videos
Tumor suppressor gene expression during normal and pathologic myocardial growth
K K Kim1, M H Soonpaa, A I Daud
1Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis 46202-4800.
The Journal of Biological Chemistry
|September 9, 1994
Summary
Tumor suppressor genes like p53 and p107 are highly expressed in embryonic cardiomyocytes but decrease with differentiation. These genes are not activated during cardiac hypertrophy, suggesting a role in development rather than pathology.
Area of Science:
- Cardiovascular Biology
- Molecular Oncology
- Cellular Differentiation
Background:
- SV40 T antigen forms complexes with host proteins (p53, p107, p193) in transformed cardiomyocytes.
- Understanding tumor suppressor gene expression is crucial for cardiac development and pathology.
Purpose of the Study:
- To investigate the expression patterns of p53 and p107 in murine myocardium during normal and pathological growth.
- To determine if tumor suppressor genes are transcriptionally activated during cardiac hypertrophy.
Main Methods:
- Monitoring p53 and p107 expression in embryonic, differentiating, and adult murine cardiomyocytes.
- Analyzing transcript levels during acute myocardial overload and isoproterenol-induced hypertrophy.
Main Results:
- p53 and p107 transcripts were high in embryonic cardiomyocytes, decreasing significantly during terminal differentiation.
- Retinoblastoma transcripts remained low throughout myocardial development.
- No transcriptional activation of examined tumor suppressor genes was observed during cardiac overload or hypertrophy.
Conclusions:
- p53 and p107 expression is developmentally regulated in cardiomyocytes, decreasing as cells differentiate.
- Tumor suppressor gene expression does not appear to be upregulated in response to cardiac hypertrophy.
- Further research is needed to elucidate the role of these genes in myocardial development and disease.